Last reviewed · How we verify
Stabilised Whole Rice Bran
At a glance
| Generic name | Stabilised Whole Rice Bran |
|---|---|
| Also known as | SWRB |
| Sponsor | RCSI & UCD Malaysia Campus |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Stabilized Whole Rice Bran (SWRB) for Mild to Moderate Atopic Dermatitis (EARLY_PHASE1)
- Pilot Feasibility of Rice Bran Supplementation in Nicaraguan Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Stabilised Whole Rice Bran CI brief — competitive landscape report
- Stabilised Whole Rice Bran updates RSS · CI watch RSS
- RCSI & UCD Malaysia Campus portfolio CI